1. Zhao, SS, Robertson, S, Reich, T, et al. Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis. Rheumatology 2020; 59(Suppl. 4): iv47–iv57.
Google Scholar | Crossref2. López-Medina, C, Jiménez-Gómez, Y, Moltó, A, et al. Cardiovascular risk factors in patients with spondyloarthritis from Northern European and Mediterranean countries: an ancillary study of the ASAS-COMOSPA project. Jt Bone Spine 2018; 85: 447–453.
Google Scholar | Crossref | Medline3. Moltó, A, Nikiphorou, E. Comorbidities in spondyloarthritis. Front Med (Lausanne) 2018; 5: 62.
Google Scholar | Crossref | Medline4. Agca, R, Heslinga, SC, Rollefstad, S, et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis 2016; 76: 17–28.
Google Scholar | Crossref | Medline5. Navarini, L, Caso, F, Costa, L, et al. Cardiovascular risk prediction in ankylosing spondylitis: from traditional scores to machine learning assessment. Rheumatol Ther 2020; 7: 867–882.
Google Scholar | Crossref | Medline6. Patel, SA, Winkel, M, Ali, MK, et al. Cardiovascular mortality associated with 5 leading risk factors: national and state preventable fractions estimated from survey data. Ann Intern Med 2015; 163: 245–253.
Google Scholar | Crossref | Medline7. Stamler, J, Stamler, R, Neaton, JD, et al. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy. Findings for 5 large cohorts of young adult and middle-aged men and women. J Am Med Assoc 1999; 282: 2012–2018.
Google Scholar | Crossref | Medline | ISI8. Yang, ZJ, Liu, J, Ge, JP, et al. Prevalence of cardiovascular disease risk factor in the Chinese population: the 20072008 China National Diabetes and Metabolic Disorders Study. Eur Heart J 2012; 33: 213–220.
Google Scholar | Crossref | Medline | ISI9. Bermudez, EA, Rifai, N, Buring, J, et al. Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol 2002; 22: 1668–1673.
Google Scholar | Crossref | Medline | ISI10. Fernandez-Real, JM, Vayreda, M, Richart, C, et al. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 2001; 86: 1154–1159.
Google Scholar | Crossref | Medline11. Papagoras, C, Voulgari, PV, Drosos, AA. Atherosclerosis and cardiovascular disease in the spondyloarthritides, particularly ankylosing spondylitis and psoriatic arthritis. Clin Exp Rheumatol 2013; 31: 612–620.
Google Scholar | Medline | ISI12. Rudwaleit, M, van der Heijde, D, Landewé, R, et al. The development of assessment of spondyloarthritis international society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009; 68: 777–783.
Google Scholar | Crossref | Medline | ISI13. Garrett, S, Jenkinson, T, Kennedy, LG, et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994; 21: 2286–2291.
Google Scholar | Medline | ISI14. Lukas, C, Landewé, R, Sieper, J, et al. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 2009; 68: 18–24.
Google Scholar | Crossref | Medline | ISI15. Calin, A, Garrett, S, Whitelock, H, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994; 21: 2281–2285.
Google Scholar | Medline | ISI16. Jenkinson, TR, Mallorie, PA, Whitelock, HC, et al. Defining spinal mobility in Ankylosing Spondylitis (AS). The Bath AS metrology index. J Rheumatol 1994; 21: 1694–1698.
Google Scholar | Medline | ISI17. Heuft-Dorenbosch, L, Spoorenberg, A, van Tubergen, A, et al. Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 2003; 62: 127–132.
Google Scholar | Crossref | Medline18. Creemers, MC, Franssen, MJ, Van’t Hof, MA, et al. Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis 2005; 64: 127–129.
Google Scholar | Crossref | Medline19. Derakhshan, MH, Goodson, NJ, Packham, JC, et al. Increased risk of hypertension associated with spondyloarthritis disease duration: results from the ASAS-COMOSPA study. J Rheumatol 2019; 46: 701–709.
Google Scholar | Crossref | Medline20. Vandanmagsar, B, Youm, YH, Ravussin, A, et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med 2011; 17: 179–189.
Google Scholar | Crossref | Medline | ISI21. Koh, KK, Han, SH, Quon, MJ. Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions. J Am Coll Cardiol 2005; 46: 1978–1985.
Google Scholar | Crossref | Medline | ISI22. Ferraz-Amaro, I, González-Juanatey, C, López-Mejias, R, et al. Metabolic syndrome in rheumatoid arthritis. Mediators Inflamm 2013; 2013: 710928.
Google Scholar | Crossref | Medline23. Muhlestein, JB, May, HT, Jensen, JR, et al. The reduction of inflammatory biomarkers by statin, fibrate, and combination therapy among diabetic patients with mixed dyslipidemia. The DIACOR (Diabetes and Combined Lipid Therapy Regimen) study. J Am Coll Cardiol 2006; 48: 396–401.
Google Scholar | Crossref | Medline24. Solomon, DH, Massarotti, E, Garg, R, Liu, J, et al. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. JAMA 2011; 305: 2525–2531.
Google Scholar | Crossref | Medline | ISI25. Sattar, N, McCarey, DW, Capell, H, et al. Explaining how “high-grade” systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003; 108: 2957–2963.
Google Scholar | Crossref | Medline | ISI26. Ferraz-Amaro, I, Prieto-Peña, D, Palmou-Fontana, N, et al. The number of traditional cardiovascular risk factors is independently correlated with disease activity in patients with psoriatic arthritis. Medicina (Kaunas) 2020; 56: 415.
Google Scholar | Crossref